open access
Pituitary apoplexy as the first manifestation of non‑functioning pituitary neuroendocrine tumour
, 1, 2, 1, 1
Affiliations- Department of Internal Medicine, Endocrinology and Diabetes, Medical University of Warsaw, Warsaw, Poland
- Department of Internal Medicine, Endocrinology and Diabetes, Mazovian Brodnowski Hospital, Warsaw, Poland
open access
Abstract
Not required for a Clinical Vignette
Abstract
Not required for a Clinical Vignette
Keywords
pituitary apoplexy; pituitary neuroendocrine tumour; pituitary haemorrhage
About this articleTitle
Pituitary apoplexy as the first manifestation of non‑functioning pituitary neuroendocrine tumour
Journal
Issue
Article type
Clinical vignette
Pages
111-112
Published online
2023-12-23
Page views
387
Article views/downloads
126
DOI
Pubmed
Bibliographic record
Endokrynol Pol 2024;75(1):111-112.
Keywords
pituitary apoplexy
pituitary neuroendocrine tumour
pituitary haemorrhage
Authors
Lukasz Dzialach
Joanna Sobolewska
Wioleta Respondek
Agnieszka Wojciechowska-Luzniak
Przemyslaw Witek
References (5)- Lewiński A, Smyczyńska J, Stawerska R, et al. National Program of Severe Growth Hormone Deficiency Treatment in Adults and Adolescents after Completion of Growth Promoting Therapy. Endokrynol Pol. 2018; 69(5): 468–524.
- Rajasekaran S, Vanderpump M, Baldeweg S, et al. UK guidelines for the management of pituitary apoplexy. Clin Endocrinol (Oxf). 2011; 74(1): 9–20.
- Gheorghe AM, Trandafir AI, Ionovici N, et al. Pituitary Apoplexy in Patients with Pituitary Neuroendocrine Tumors (PitNET). Biomedicines. 2023; 11(3).
- Biagetti B, Simò R. Pituitary Apoplexy: Risk Factors and Underlying Molecular Mechanisms. Int J Mol Sci. 2022; 23(15).
- Marx C, Rabilloud M, Borson Chazot F, et al. A key role for conservative treatment in the management of pituitary apoplexy. Endocrine. 2021; 71(1): 168–177.
